Evidence map›Paper›PMID 26465382›Full record

ArticleAnalytical chemistry2015

Parts per Million Powder X-ray Diffraction.

Justin A Newman, Paul D Schmitt, Scott J Toth, Fengyuan Deng, Shijie Zhang, Garth J Simpson

Abstract read
In one paragraph

Article in Analytical chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Compositional Analysis of Complex Mixtures using Automatic MicroED Data Collection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Microstructure and Corrosion Behavior of Sn-Zn Alloys.Materials (Basel, Switzerland) · 2022
    Article
  14. Novel TiOMembranes · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Nanocrystalline Electrodeposited Fe-W/AlFrontiers in chemistry · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Justin A NewmanDepartment of Chemistry, Purdue University , West Lafayette, Indiana, United States.
Paul D SchmittDepartment of Chemistry, Purdue University , West Lafayette, Indiana, United States.
Scott J TothDepartment of Chemistry, Purdue University , West Lafayette, Indiana, United States.
Fengyuan DengDepartment of Chemistry, Purdue University , West Lafayette, Indiana, United States.
Shijie ZhangDepartment of Chemistry, Purdue University , West Lafayette, Indiana, United States.
Garth J SimpsonDepartment of Chemistry, Purdue University , West Lafayette, Indiana, United States.

Funding

Nonlinear Optical Imaging for Guiding Protein Structure DeterminationR01GM103401 · NIGMS · PURDUE UNIVERSITY · PI SIMPSON, GARTH JASON · 2012 to 2018
$1.7M
Ultrafast Nonlinear Optical Approaches toward High-Throughput Membrane Protein NaR01GM103910 · NIGMS · PURDUE UNIVERSITY · PI SIMPSON, GARTH JASON · 2013 to 2016
$1.1M
NIGMS NIH HHS R01 GM103401NIGMS NIH HHS R01GM103401NIGMS NIH HHS R01 GM103910NIGMS NIH HHS R01GM103910
6 · The paper itself

Abstract

Here we demonstrate the use of second harmonic generation (SHG) microscopy-guided synchrotron powder X-ray diffraction (PXRD) for the detection of trace crystalline active pharmaceutical ingredients in a common polymer blend. The combined instrument is capable of detecting 100 ppm crystalline ritonavir in an amorphous hydroxypropyl methylcellulose matrix with a high signal-to-noise ratio (>5000). The high spatial resolution afforded by SHG microscopy allows for the use of a minibeam collimator to reduce the total volume of material probed by synchrotron PXRD. The reduction in probed volume results in reduced background from amorphous material. The ability to detect low crystalline loading has the potential to improve measurements in the formulation pipeline for pharmaceutical solid dispersions, for which even trace quantities of crystalline active ingredients can negatively impact the stability and bioavailability of the final drug product.

Indexed as

Limit of DetectionPowder Diffraction

Identifiers

PMID26465382
PMCPMC4747326

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.